All articles by Phillip Broadwith – Page 8
-
BusinessAllergan to buy fat-freezing firm Zeltiq
$2.5bn deal adds to firm’s cosmetic and aesthetic treatments
-
BusinessDaiichi Sankyo to close R&D sites in India and Japan
Closures are part of an ongoing reorganisation aimed at increasing productivity
-
BusinessSabic takes control of Shell petrochemicals joint venture
$820m sale of Saudi Arabian plants continues Shell’s global reorganisation programme
-
OpinionHow much is your chief executive worth?
The executive pay and equality debate is here to stay
-
BusinessLilly buys CoLucid for migraine drugs
US firm also laying off 485 sales staff after Alzheimer’s drug failure
-
BusinessMerck & Co settles cancer antibody patent dispute
US firm will pay Bristol-Myers Squibb and Ono $625m plus royalties on future sales of immunotherapy
-
BusinessTeva hit with fines and patent loss
Double whammy as firm settles subsidiary pay-for-delay suit and courts invalidate patents on multiple sclerosis drug
-
BusinessJ&J to buy Actelion for $30bn
Actelion’s R&D will spin out as a new company, while Janssen will take on in-market and late-stage medicines
-
BusinessBiogen pays $1.25bn to protect multiple sclerosis drug sales
Agreement with Forward Pharma gives Biogen license to keep selling blockbuster Tecfidera
-
-
-
BusinessFormer Valeant and Philidor executives arrested for fraud
Prosecutors allege the men masterminded a kickback scheme between Valeant and the speciality pharmacy
-
BusinessOCP to invest $3.7bn in Ethiopian fertiliser plant
Output from joint venture between Ethiopian government and Moroccan state phosphate group will exceed domestic demand
-
OpinionUncertainty around Trump presidency is harmful to industry
Uncertainty is anathema to industry. Trump and Brexit are frustrations, but the wheels do not stop.
-
OpinionRegulatory tightropes
When lobbying and marketing clash with scientific evidence, regulators walk a fine line
-
NewsExplainer: Are ‘flushable’ wet wipes really flushable?
Water companies are calling for all wipes to be classified as unflushable until an international standard is agreed
-
BusinessThird fatality confirmed in BASF incident
Crackers and related plants will restart over coming days
-
BusinessExplosion at BASF kills at least two
Six workers injured and a further two missing in Ludwigshafen, Germany
-
BusinessChemical activity on demand
Aqdot controls the release of encapsulated cargoes using supramolecular chemistry
-
OpinionBooster shot
Zika and Ebola have highlighted the pharmaceutical industry’s ability to respond to critical needs